Omics! Omics!

A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery

Monday, November 06, 2017

A Nucleotide Mixture-Based Error Correcting Short Read Chemistry

›
Sometimes polony-style short read sequencing seems like old news.  The underlying technology has been commercially available for over a deca...
2 comments:
Wednesday, November 01, 2017

AlphaGo & Biology

›
A comment was left on an early piece suggesting I comment on the recent AlphaGo paper and the possible applicability of this approach to bio...
4 comments:
Tuesday, October 17, 2017

Mission Bio Launches Tapestri Single Cell Platform

›
The fact that tumors and their immediate environment is genetically heterogeneous has long been known, but tools for high-throughput assessm...
1 comment:
Friday, October 13, 2017

iGenomX Riptide Kits Promise a Sea of Data

›
A theme for me in my six years on Starbase has been addressing the challenge of cost-effectively sequencing many small genomes.  While seque...
2 comments:
Wednesday, October 04, 2017

PacBio's Frankenpatent on Error Correction

›
Well, here we go again.  Pacific Biosciences launched yet another patent lawsuit towards Oxford Nanopore at the end of September, and alread...
2 comments:
Sunday, October 01, 2017

Dispatches from CDC AMD Day 2017

›
I had the singular honor and pleasure of speaking this past Monday at the Center for Disease Control and Prevention's Advanced Molecular...
1 comment:
Sunday, September 24, 2017

Why Is LISP So Rare in Bioinformatics?

›
LISP is one of the oldest computer languages and perhaps one of the most influential of the early ones.  Some of the other well-known Eisen...
6 comments:
Monday, September 18, 2017

Teaching Biology Evidence: Old or New?

›
I've been toying over a week with writing something based on an interesting Twitter discussion started by Dr. Laura Williams (@MicroWave...
Tuesday, August 29, 2017

The Curse of Spammotation Lives!

›
High throughput sequencing of genomes is over twenty years old, which demanded the development of automated pipelines for annotating this da...
1 comment:
Tuesday, August 15, 2017

DNA vs. the Machine

›
Last week's news contained a story sure to raise eyebrows.  A group of computer security researchers from the University of Washington c...
1 comment:
Saturday, August 05, 2017

Computational Biology & Math: Am I Just Faking It?

›
Over on Quora a common type of question is "Can I be a computational biologist if I am now an X".  Personally I take a very broad ...
1 comment:
Friday, July 21, 2017

A Third GridION X5 Pricing Plan

›
When Oxford Nanopore announced their GridION X5 instrument in March , I and others attempted to parse the difference between the two pricing...
5 comments:
Wednesday, June 28, 2017

STAT Proves Not Resistant To Antibiotic Tropes

›
Tuesday's Boston Globe carried a piece originating from STAT news on an interesting natural product antibiotic, pleuromutilin.  A resea...
Wednesday, June 14, 2017

New Life in the Sanger Market

›
In my bit on " I'm not dead yet" technologies recently, I included large scale Sanger sequencing. That reflects to a large de...
6 comments:
Tuesday, June 06, 2017

Ice Ghosts:A Shortage of Maps

›
I'm going to step outside the usual topic space here and cover an interesting but frustrating book I read partly on the flight to London...
3 comments:
Monday, May 22, 2017

What Is (and Is Not) Sequence Assembly?

›
In the closing talk of the pre-London Calling workshop, Hans Jansen had closed his presentation with a question whether at some future date ...
1 comment:
Thursday, May 18, 2017

London Calling 2017: Plant & Animal de novo Genomes

›
Okay, I'm desperately behind on writing up the external science from London Calling.  Not helpful that I claimed I would not only do so,...
Sunday, May 14, 2017

SFAF & I'm Not Dead Yet Technologies

›
Jonathan Jacobs posted his annual reminder that the Sequencing, Finishing and Analysis in the Future Meeting (SFAF) will be this week.  Alas...
1 comment:
Tuesday, May 09, 2017

London Calling 2017: A Theme of Consolidation

›
London Calling 2017 came to a close last Friday.  Any excuses of jet lag or nights running up ONT's bar tab won't hold up much longe...
10 comments:
Thursday, May 04, 2017

Nanopore Workshop Notes

›
I attended on Wednesday the London Calling pre-conference workshop, an add-on for those wishing for help getting started with MinION sequenc...
4 comments:
‹
›
Home
View web version

About Me

My photo
Keith Robison
Dr. Robison spent 10 years at Millennium Pharmaceuticals working with various genomics & proteomics technologies & working on multiple teams attempting to apply these throughout the drug discovery process. He spent 2 years at Codon Devices working on a variety of protein & metabolic engineering projects as well as monitoring a high-throughput gene synthesis facility. After a brief bit of consulting, he rejoined the cancer drug discovery field at Infinity Pharmaceuticals in May 2009. In September 2011 he joined Warp Drive Bio, a startup applying genomics to natural product drug discovery. In February 2019 he joined Ginkgo Bioworks, a synthetic biology company. Other recurring characters in this blog are his late loyal Shih Tzu Amanda, his current Shih Poo Lily and his now adult son alias TNG (The Next Generation). Dr. Robison can be reached via his Gmail account, keith.e.robison@gmail.com You can also follow him on Twitter as @OmicsOmicsBlog.
View my complete profile
Powered by Blogger.